Park Avenue Securities LLC reduced its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 40.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,586 shares of the business services provider's stock after selling 14,256 shares during the period. Park Avenue Securities LLC's holdings in Genpact were worth $906,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Cornerstone Planning Group LLC acquired a new stake in shares of Genpact during the 1st quarter valued at about $27,000. Richardson Financial Services Inc. acquired a new stake in shares of Genpact during the 1st quarter valued at about $35,000. SVB Wealth LLC acquired a new stake in shares of Genpact during the 1st quarter valued at about $41,000. Kestra Investment Management LLC acquired a new stake in shares of Genpact during the 1st quarter valued at about $56,000. Finally, Global X Japan Co. Ltd. acquired a new stake in shares of Genpact during the 1st quarter valued at about $57,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Trading Up 1.0%
Shares of NYSE G opened at $42.21 on Friday. Genpact Limited has a 1-year low of $37.82 and a 1-year high of $56.76. The company has a market cap of $7.36 billion, a PE ratio of 14.02, a P/E/G ratio of 1.45 and a beta of 0.92. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average of $43.73 and a two-hundred day moving average of $45.19.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, topping analysts' consensus estimates of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same period in the previous year, the firm posted $0.79 earnings per share. The company's revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th were paid a $0.17 dividend. The ex-dividend date of this dividend was Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.6%. Genpact's payout ratio is currently 22.59%.
Analysts Set New Price Targets
G has been the topic of a number of recent analyst reports. Needham & Company LLC boosted their price target on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research report on Friday, August 8th. JPMorgan Chase & Co. reduced their price target on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 20th. Wall Street Zen lowered shares of Genpact from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Genpact in a research report on Thursday, July 17th. They issued a "hold" rating and a $47.00 price target on the stock. Finally, Mizuho boosted their price target on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research report on Tuesday, July 1st. Three investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $52.29.
Check Out Our Latest Stock Report on G
Insider Transactions at Genpact
In related news, CEO Balkrishan Kalra sold 55,000 shares of the business's stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the sale, the chief executive officer directly owned 295,246 shares of the company's stock, valued at $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Piyush Mehta sold 76,902 shares of the business's stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the sale, the senior vice president directly owned 134,880 shares of the company's stock, valued at approximately $5,743,190.40. This trade represents a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.07% of the company's stock.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.